USPTO serial 78804270
DEDOXA
Reviewed by CopyMark Law Group
Reg. 3669437Status 710
- Filing date
- Status date
- Registration date
- Aug 18, 2009
- Examiner
- SAUNDERS, ANDREA DAWN
- Law office
- PETITIONS OFFICE
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with DEDOXA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
SANTHERA PHARMACEUTICALS (SCHWEIZ) GMBH
CH-4410 Liestal, CH
Other trademarks owned by SANTHERA PHARMACEUTICALS (SCHWEIZ) GMBH
SANTHERA PHARMACEUTICALS (SCHWEIZ) GMBH
CH-4410 Liestal, CH
Other trademarks owned by SANTHERA PHARMACEUTICALS (SCHWEIZ) GMBH
SANTHERA PHARMACEUTICALS (SCHWEIZ) GMBH
CH-4410 Liestal, CH
Other trademarks owned by SANTHERA PHARMACEUTICALS (SCHWEIZ) GMBH
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Patrick J. Concannon
Patrick J. Concannon Locke Lord LLPPO BOX 1470Church Street StationNEW YORK, NY 10008-1470Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals used in industry and science | SECTION 8 - CANCELLED | — |
| 005 | Pharmaceutical, veterinary and sanitary preparations, namely, chemical products for use in the treatment of muscular dystrophy, muscle wasting, atrophy, neuromuscular diseases, cardiomyopathies, ataxias, optic nerve degradation, neurological indications and memory loss | SECTION 8 - CANCELLED | — |
| 042 | Computer programming for scientific and industrial research in the fields of cell cultures, muscular dystrophy, muscle wasting, atrophy, neuromuscular diseases, cardiomyopathies, ataxias, optic nerve degradation, neurological indications and memory loss; scientific research for cellular test systems that evaluate drugs and antibodies; scientific research for finding pharmacologically active compounds and animal models for neuromuscular diseases; scientific research in the fields of muscular dystrophy, muscle wasting, atrophy, neuromuscular diseases, cardiomyopathies, ataxias, optic nerve degradation, neurological indications and memory loss | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by SANTHERA PHARMACEUTICALS (SCHWEIZ) GMBH
- Other trademarks owned by SANTHERA PHARMACEUTICALS (SCHWEIZ) GMBH
- Other trademarks owned by SANTHERA PHARMACEUTICALS (SCHWEIZ) GMBH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named DEDOXA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 25, 2016 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jan 26, 2016 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 19, 2010 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 19, 2010 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 18, 2009 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 5, 2009 | CHPB | POST PUBLICATION AMENDMENT - ENTERED | — |
| Jul 29, 2009 | APET | ASSIGNED TO PETITION STAFF | — |
| Jul 15, 2009 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Jun 2, 2009 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 13, 2009 | NPUB | NOTICE OF PUBLICATION | — |
| Apr 28, 2009 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 28, 2009 | DMCC | DATA MODIFICATION COMPLETED | — |
| Apr 27, 2009 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 24, 2009 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 24, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 24, 2009 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Apr 15, 2009 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Apr 15, 2009 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Apr 15, 2009 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Apr 15, 2009 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 15, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 13, 2009 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Oct 14, 2008 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Oct 14, 2008 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Oct 14, 2008 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Sep 2, 2008 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Feb 28, 2008 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Feb 28, 2008 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Feb 28, 2008 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Feb 28, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 28, 2008 | ALIE | ASSIGNED TO LIE | — |
| Jan 28, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 28, 2008 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Aug 3, 2007 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Aug 3, 2007 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Aug 3, 2007 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Jan 25, 2007 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jan 25, 2007 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jan 24, 2007 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 23, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 23, 2007 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 6, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 24, 2006 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 24, 2006 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 23, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 7, 2006 | NWAP | NEW APPLICATION ENTERED | — |